Pablo Ingelmo: Clinical Trials

1 trial sponsored by Pablo Ingelmo, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Unknown 1

Follow Pablo Ingelmo: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assessment of the Efficacy of the Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Daily Headache in Children and Adolescents.
Sphenopalatine ganglion block with 0.5% bupivacaine, Sphenopalatine ganglion block with saline - Chronic Daily Headache, Post-Traumatic Headache
Not applicableUnknownPablo Ingelmo1202022-02-052022-01-28

Conditions studied

Headache Disorders (1)  ·  Post-Traumatic Headache (1)

Interventions

Bupivacaine (1)  ·  Sodium Chloride (1)  ·  Sphenopalatine Ganglion Block (1)

Countries

Canada (1)